Pricing Log in Create free account

BlossomHill Therapeutics, Inc. (BLSM) vs CorMedix Inc (CRMD)

BlossomHill Therapeutics, Inc. and CorMedix Inc are both Biotechnology companies. BlossomHill Therapeutics, Inc. and CorMedix Inc are of similar size ($407.6M and $392.6M). BlossomHill Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; CorMedix Inc trades at 2.2×. CorMedix Inc has the higher net margin (40.5% vs 0.00%) and the higher return on invested capital (38.8% vs 0.00%). Across the 13 metrics below, CorMedix Inc leads on 10 and BlossomHill Therapeutics, Inc. on 3.

Valuation

Metric BLSM CRMD Biotechnology median
P/E n/m 2.20 10.60
P/S n/m 0.90 9.40
P/B n/m 0.90 2.13
Price to free cash flow n/m 1.66 25.18
EV/EBITDA 0.82 1.20 0.66
EV/Sales n/m 0.66 9.02
Earnings yield (200.83%) 45.47% (32.88%)
Free cash flow yield (180.38%) 60.23% (23.13%)

Profitability

Metric BLSM CRMD Biotechnology median
Gross margin — 82.78% 68.51%
Operating margin 0.00% 46.95% 0.00%
Net margin 0.00% 40.49% 0.00%
Free cash flow margin 0.00% 54.17% 0.00%
Return on equity 0.00% 54.93% (51.96%)
Return on assets 0.00% 32.36% (46.06%)
Return on invested capital 0.00% 38.84% 0.00%

Growth

Metric BLSM CRMD Biotechnology median
Revenue growth (TTM) — 280.50% 6.76%
EPS growth (last fiscal year) (85.30%) 780.00% 29.88%
Revenue growth, 5-year CAGR — 305.79% 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric BLSM CRMD Biotechnology median
Debt to equity 0.00 0.32 0.00
Current ratio 5.42 2.56 4.97
Net debt to EBITDA 2.15 (0.02) 1.01

Dividend

Metric BLSM CRMD Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric BLSM CRMD Biotechnology median
Market cap 392.55m 407.64m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack